Treatment of Corneal Infection
For bacterial keratitis, the most effective treatment is topical fluoroquinolones such as moxifloxacin 0.5% applied frequently, starting with loading doses every 5-15 minutes followed by hourly application for severe cases. 1
Initial Assessment and Diagnosis
- Corneal infections should be examined by an ophthalmologist as part of the initial assessment to determine the severity and type of infection 1
- Fluorescein staining should be performed to identify epithelial defects and assess the extent of corneal involvement 1
- Smears and cultures are specifically indicated when:
- The corneal infiltrate is central, large (>2 mm), or has significant stromal involvement/melting
- The infection is chronic or unresponsive to broad-spectrum antibiotics
- There is a history of corneal surgeries
- Atypical features suggest fungal, amoebic, or mycobacterial keratitis
- Multiple infiltrates are present on the cornea 1
Treatment Algorithm for Bacterial Keratitis
Mild to Moderate Bacterial Keratitis
- Begin with topical fluoroquinolones (e.g., moxifloxacin 0.5%) applied 1 drop every hour while awake for the first 24-48 hours 1, 2
- After 48 hours of improvement, reduce frequency to every 2 hours while awake 3
- Continue treatment for 7-10 days, not tapering below 3-4 times daily to avoid developing resistance 3
- Add a cycloplegic agent if substantial anterior chamber inflammation is present 1
Severe Bacterial Keratitis
- Begin with loading doses of topical antibiotics every 5-15 minutes followed by hourly application 1, 4
- For central or large infiltrates, consider combination therapy with fortified antibiotics 1
- Daily ophthalmological review is necessary during the acute illness 1
- Ocular hygiene to remove inflammatory debris should be performed daily 1
Contact Lens-Related Keratitis
- Immediately discontinue contact lens wear 4
- Higher risk of Pseudomonas infection requires aggressive antibiotic therapy 4
- Avoid bandage contact lens use in these cases 5
Monitoring Treatment Response
Positive signs of response to therapy include:
- Reduced pain and discharge 3
- Decreased eyelid edema and conjunctival injection 3
- Consolidation and sharper demarcation of stromal infiltrate perimeter 3
- Decreased density of stromal infiltrate and reduced stromal edema 3
- Initial re-epithelialization and cessation of progressive corneal thinning 3
Special Considerations
Corticosteroid Use
- Corticosteroids may be considered after 24-48 hours when the causative organism is identified and/or infection is responding to therapy 1
- Topical corticosteroids should be avoided in cases of suspected Acanthamoeba, Nocardia, or fungal infections 1
- Topical corticosteroids can mask signs of corneal infection 1
Fungal Keratitis
- Requires different treatment approach with antifungal agents such as natamycin 5% for filamentous fungi 6
- Topical amphotericin B (0.1-0.3%) is often the treatment of choice for Candida infections 6
- Avoid corticosteroids in suspected fungal infections 1, 6
Complicated Cases
- For persistent epithelial defects where infection is controlled, consider adjunctive therapies such as lubrication, bandage contact lens, or amniotic membrane coverage 1
- Application of amniotic membrane may decrease inflammation and stabilize the ocular surface 1
- For cases with corneal thinning or impending perforation, consider tissue adhesive, penetrating keratoplasty, or lamellar keratoplasty 1
Common Pitfalls and Caveats
- Avoid patching the eye in contact lens wearers with corneal abrasions due to increased risk of bacterial keratitis 1, 5
- Most antibiotic eye drops should not be tapered below 3-4 times daily as low doses are subtherapeutic and may increase antibiotic resistance 3
- Modification of therapy should be considered if the eye shows no improvement within 48 hours 3
- Be aware of increasing resistance of MRSA and Pseudomonas aeruginosa to topical fluoroquinolones 1
- Prolonged use of topical antibiotics can cause toxicity, so taper as infection improves 3
Emerging Treatments
- Corneal cross-linking has shown promise as an adjunctive treatment for bacterial keratitis, especially for more shallow infiltrates 1
- Topical povidone-iodine 1.25% has been shown to be as effective as topical antibiotics in some studies and may be a cost-effective alternative in developing countries 1